Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Implementing change

So then, what we have here is Johnson, Helmut and Felcyn holding all the power and we have none? If we notify the BoD within the proper timeframe that the stockholders intend to present the proposal for consideration at the annual meeting, are you saying that those three can say no, and we will never ever have a chance to see our proposal on the proxy?

Something seems terribly wrong with that idea.

Share
New Message
Please login to post a reply